CNS Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CNSP and other ETFs, options, and stocks.About CNSP
CNS Pharmaceuticals, Inc. is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. Its product pipeline includes berubicin, and CNS-12.
CEOJohn M. Climaco
CEOJohn M. Climaco
Employees5
Employees5
HeadquartersHouston, Texas
HeadquartersHouston, Texas
Founded2017
Founded2017
Employees5
Employees5
CNSP Key Statistics
Market cap4.91M
Market cap4.91M
Price-Earnings ratio-0.13
Price-Earnings ratio-0.13
Dividend yield—
Dividend yield—
Average volume13.92K
Average volume13.92K
High today$8.00
High today$8.00
Low today$7.78
Low today$7.78
Open price$7.89
Open price$7.89
Volume13.13K
Volume13.13K
52 Week high$114.00
52 Week high$114.00
52 Week low$4.93
52 Week low$4.93
Stock Snapshot
CNS Pharmaceuticals(CNSP) stock is priced at $7.79, giving the company a market capitalization of 4.91M. It carries a P/E multiple of -0.13.
On 2025-12-15, CNS Pharmaceuticals(CNSP) stock moved within a range of $7.78 to $8.00. With shares now at $7.79, the stock is trading +0.1% above its intraday low and -2.6% below the session's peak.
Trading volume for CNS Pharmaceuticals(CNSP) stock has reached 13.13K, versus its average volume of 13.92K.
Over the past 52 weeks, CNS Pharmaceuticals(CNSP) stock has traded between a high of $114.00 and a low of $4.93.
Over the past 52 weeks, CNS Pharmaceuticals(CNSP) stock has traded between a high of $114.00 and a low of $4.93.
People also own
Based on the portfolios of people who own CNSP. This list is generated using Robinhood data, and it’s not a recommendation.